Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
117 Leser
Artikel bewerten:
(0)

Global Angiography Devices Market to 2019: Siemens, GE healthcare, Toshiba Medical, Shimadzu, Royal Philips Electronics, St Jude Medical & Abbott Vascular Dominate the $27 Billion Industry

DUBLIN, Feb .10, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/7h6xdr/angiography) has announced the addition of the "Angiography Devices Market by Technology, Products, Application & End-Users - Global Forecast to 2019" report to their offering.

600769

The global angiography devices market is estimated to reach $27.7 billion in 2019, at a CAGR of 4.4% from 2014 to 2019

Market growth will be attributed to innovative new product launches, rising demand for early diagnosis and treatment by the aging population, and increasing awareness on the benefits of early diagnosis & treatment of cardiovascular disease.

The angiography devices market studied in this report is mainly segmented by technology, products, applications, procedures, indications, and end users. Based on products, the market is further segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. On the basis of technology, the market is segmented into X-ray, computed tomography, and magnetic resonance angiography. By application, the market is segmented into diagnostic and therapeutic. The market, by indication, can be divided into known/suspected CAD, valvular heart disease, congenital heart disease, and congenital heart failure. Based on procedure, the market is segmented into coronary angiography, micro-angiography, neuro-vascular, peripheral angiography, post-mortem CT angiography, and other procedures (radiofrequency (RF) tumor ablation studies, other RF procedures). The end-user market covers hospitals, diagnostic centers, and academic research laboratories.

Developed geographies like North America & Europe are saturated markets and expected to grow at a slower rate in the forecast period, whereas the Asian market is expected to witness the highest growth due to increasing volume of procedures (which is caused by the rising aging population and patient base). The North American and Europeean markets will grow mainly because of the tendency to replace old devices with new, advanced devices.

Key players in angiography devices market are Siemens Healthcare (Germany), GE Healthcare (U.K.), Toshiba Medical System Corporation (Japan), Shimadzu Corporation (Japan), Royal Philips Electronics (Netherlands), St. Jude Medical, Inc. (U.S.), and Abbott Vascular (Abbott Laboratories) (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary


4 Premium Insights

5 Market Overview

6 Angiography Devices Market, By Technology

7 Angiography Devices Market, By Products

8 Angiography Devices Market, By Type Of Application

9 Angiography Devices Market, By Procedure

10 Angiography Devices Market, By Indication

11 Angiography Devices Market, By End-Users

12 Geography Analysis

13 Competitive Landscape

14 Company Profiles

- Abbott Vascular
- Boston Scientific Corporation
- Cordis Corporation (A Jnj Company)
- GE Healthcare
- Medtronic Inc.
- Philips Healthcare
- ST. Jude Medical
- Shimadzu Corporation
- Siemens Healthcare
- Toshiba Corporation

For more information visit http://www.researchandmarkets.com/research/7h6xdr/angiography

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.